• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.28% Nasdaq Up0.17%

    Amarantus Bioscience Holdings, Inc (AMBS)

    -Other OTC
    1.20 0.00(0.00%) Oct 12, 3:59PM EDT
    |Pre-Market : NaN
    ProfileGet Profile for:
    Amarantus Bioscience Holdings, Inc
    655 Montgomery Street
    Suite 900
    San Francisco, CA 94111
    United States - Map
    Phone: 415-688-4484
    Fax: 408-852-4427
    Website: http://www.amarantus.com

    Index Membership:N/A
    Full Time Employees:10

    Business Summary 

    Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostics and therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, and ophthalmological disorders. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with relapsing-remitting multiple sclerosis at first clinical presentation. Its therapeutic products in development comprise Eltoprazine, a small molecule drug that is in Phase II clinical trials for the treatment of Parkinson’s disease Levadopa-Induced Dyskinesia and adult attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including iretinitis pigmentosa, Parkinson’s disease, cardiac ischemia, and stroke. It is also developing NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson’s disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University to develop its full thickness skin replacement product. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus Bioscience Holdings, Inc. in April 2013. Amarantus Bioscience Holdings, Inc. was founded in 2008 and is based in San Francisco, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Amarantus Bioscience Holdings, Inc

    Key Executives 
    Mr. Gerald E. Commissiong , 32
    Chief Exec. Officer, Pres and Director
    Mr. Robert E. Farrell J.D., Esq., 65
    Chief Financial Officer
    Dr. John Wesley Commissiong Ph.D., 70
    Chief Scientific Officer, Director and Member of Scientific Advisory Board
    Mr. Marc E. Faerber , 60
    VP of Financial Operations, Treasurer, Sec. and Corp. Controller
    Aimee Boutcher ,
    Director of Investor Relations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders